Dr. Sarah Rutherford is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, New York-Presbyterian Hospital, and NewYork-Presbyterian/Columbia University Irving Medical Center. She received her medical degree from University of Virginia School of Medicine and has been in practice 8 years. She is one of 369 doctors at New York-Presbyterian Hospital and one of 115 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Oncology. She has more than 30 publications and over 200 citings.
Office
520 East 70th Street Starr Pavilion, 3rd Floor New York, NY 10021
Sarah C Rutherford, Jun Yin, Levi D Pederson, Kristie A Blum, Peter Martin, Sin-Ho Jung, Barbara Grant, Cara Rosenbaum, Bruce D Cheson, Nancy L Bartlett, Sumithra J Ma...> ;Blood Advances. 2024 Mar 26
David A Qualls, Nicholas Lambert, Paolo F Caimi, Mwanasha Merrill, Priyanka Pullarkat, Richard C Godby, David A Bond, Graham T Wehmeyer, Jason Romancik, Behzad Amoozga...> ;Blood. 2023 Dec 28
Michael Dickinson, Javier Briones, Alex F. Herrera, Eva González-Barca, Nilanjan Ghosh, Raul Cordoba, Sarah C. Rutherford, Eirini Bournazou, Emily Labriola-Tompkins, I...> ;Blood Advances. 2021 Nov 23
Sarah C. Rutherford, Jeremy S. Abramson, Nancy L. Bartlett, Stefan K. Barta, Nadia Khan, Robin Joyce, Kami J. Maddocks, Trisha Ali-Shaw, Silvia Senese, Ying Yuan, Jaso...> ;The Lancet. Haematology. 2021 Oct 8
Nina Orfali, Yuliya S. Jhanwar, Calvin Koo, Michelle Pasciolla, Maria Baldo, Edwidge Cuvilly, Richard R. Furman, Usama Gergis, June Greenberg, Danielle Guarneri, Jingm...> ;Leukemia & Lymphoma. 2021 Feb 13
Kelly M. Trevino, Sarah C. Rutherford, Chrystal Marte, Daniel Jie Ouyang, Peter Martin, Holly G. Prigerson, John P. Leonard> ;Journal of Palliative Medicine. 2020 May 29
Sarah C. Rutherford, Michael Herold, Wolfgang Hiddemann, L. Kostakoglu, Robert Marcus, Maurizio Martelli, Laurie H. Sehn, Marek Trněný, Judith Trotman, Umberto Vitolo,...> ;Blood Advances. 2020 Apr 28
Kah Poh Loh, Andrea Baran, Christina Lee, Alfadel Alshaibani, Sarah C. Rutherford, John Hu, Carla Casulo, Paul M. Barr, Jonathan W. Friedberg, Patrick M. Reagan> ;Leukemia & Lymphoma. 2019 Jul 8
Peter Martin, Jia Ruan, Richard R. Furman, Sarah C. Rutherford, John N. Allan, Zhengming Chen, Xiangao Huang, Maurizio DiLiberto, Selina Chen-Kiang, John P. Leonard> ;Leukemia & Lymphoma. 2019 May 23
Sarah C. Rutherford, Angela A. Fachel, Sheng Li, Seema Sawh, Ashlesha Muley, Jennifer Ishii, Ashish Saxena, Pilar M. Dominguez, Eloisi Caldas Lopes, Xabier Agirre, Nya...> ;Blood. 2018 Aug 16
Sarah C. Rutherford, Eric N Stewart, Zhengming Chen, Amy Chadburn, Natasha E. Wehrli, Koen van Besien, Peter Martin, Richard R. Furman, John P. Leonard, Leandro Cerchi...> ;Leukemia & Lymphoma. 2018 Jan 2
Peter Martin, Richard R. Furman, Sarah C. Rutherford, Jia Ruan, Scott Ely, June Greenberg, Morton Coleman, Stanley J. Goldsmith, John P. Leonard> ;Leukemia & Lymphoma. 2015 Mar 10
Extracellular Vesicles in DLBCL Provide Abundant Clues to Aberrant Transcriptional Programming and Genomic Alterations
Sarah C Rutherford, Ashish Saxena, Rita Shaknovich, Blood
Abstracts/Posters
Utility and Patterns of Use of PET/CT and Bone Marrow Biopsy for Staging in Non-Hodgkin Lymphoma in the Clinical Setting: A Retrospective Analysis Using the LEO Database
Sarah C. Rutherford, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
North American Practice Patterns for PET-2 Positive Hodgkin Lymphoma
Sarah C. Rutherford, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Microenvironmental Signatures Reveal Biological Subtypes of Diffuse Large B-Cell Lymphoma (DLBCL) Distinct from Tumor Cell Molecular Profiling
Sarah C. Rutherford, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Non-Destructive Post-Transplant Lymphoproliferative Disorder Shows Distinct Clinical Features with HHV-6 Reactivation in a Subset
Sarah C. Rutherford, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Major Eligibility Expansion Brings Moment of Truth for COVID Vaccines: Will Florida’s Young People Want Them?April 2nd, 2021
AI Therapeutics Announces That a Common LAM-002 Mechanism in Cancer and Neurodegenerative Diseases Shows Antitumor Activity in the Clinic and Hope for ALSJanuary 16th, 2020
LAM Therapeutics Announces Progress of Its Clinical Portfolio with FDA Clearance of New Trial in Leukemia and Advancement of Clinical Trial in LymphomaNovember 30th, 2017